1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with Leukemia, Myeloid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beckstrøm, KJ; Bettaïeb, A; Laurent, G; Lautier, D; Lehne, G; Maestre, N; Plo, I | 1 |
| Grazide, S; Jaffrézou, JP; Laurent, G; Lerouge, S; Terrisse, AD | 1 |
2 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Leukemia, Myeloid
| Article | Year |
|---|---|
Influence of ceramide metabolism on P-glycoprotein function in immature acute myeloid leukemia KG1a cells.
Topics: Acute Disease; Antigens, CD; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Ceramides; Daunorubicin; Drug Interactions; Gangliosides; Glucosylceramides; Humans; Lactosylceramides; Leukemia, Myeloid; Morpholines; Phosphorylation; Sphingosine; Tumor Cells, Cultured; Vincristine | 2002 |
Cytoprotective effect of glucosylceramide synthase inhibition against daunorubicin-induced apoptosis in human leukemic cell lines.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Glucosyltransferases; Glycosylation; HL-60 Cells; Humans; Leukemia, Myeloid; Morpholines; Protective Agents; U937 Cells | 2004 |